A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Participants With Systemic Lupus Erythematosus

Teva Investigational Site 501, Budapest

Teva Investigational Site 102, Brussels

Teva Investigational Site 101, Liège

Teva Investigational Site 502, Debrecen

Teva Investigational Site 100, Yvoir

Teva Investigational Site 500, Zalaegerszeg

Teva Investigational Site 9, Manhasset

Teva Investigational Site 403, Berlin

Teva Investigational Site 26, Pittsburgh

Teva Investigational Site 25, Duncansville

Teva Investigational Site 36, Baltimore

Teva Investigational Site 406, Hamburg

Teva Investigational Site 19, Arlington

Teva Investigational Site 18, Durham

Teva Investigational Site 2, Monroe

Teva Investigational Site 28, Charlotte

Teva Investigational Site 15, Charleston

Teva Investigational Site 38, Stockbridge

Teva Investigational Site 8, Atlanta

Teva Investigational Site 31, Atlanta

Teva Investigational Site 4, Aventura

Teva Investigational Site 35, Fort Lauderdale

Teva Investigational Site 1, Jupiter

Teva Investigational Site 11, Tampa

Teva Investigational Site 32, Clearwater

Teva Investigational Site 27, Birmingham

Teva Investigational Site 752, Santander

Teva Investigational Site 404, Düsseldorf

Teva Investigational Site 37, Lexington

Teva Investigational Site 750, Seville

Teva Investigational Site 302, Nantes

Teva Investigational Site 22, Ann Arbor

Teva Investigational Site 402, Aachen

Teva Investigational Site 33, Milwaukee

Teva Investigational Site 405, Mainz

Teva Investigational Site 301, Lille

Teva Investigational Site 304, Strasbourg

Teva Investigational Site 21, Oklahoma City

Teva Investigational Site 300, Paris

Teva Investigational Site 39, Mesquite

Teva Investigational Site 29, Dallas

Teva Investigational Site 303, Paris

Teva Investigational Site 905, Ivano-Frankivsk

Teva Investigational Site 24, Temple

Teva Investigational Site 40, Houston

Teva Investigational Site 6, Houston

Teva Investigational Site 34, San Antonio

Teva Investigational Site 904, Lviv

Teva Investigational Site 30, Aurora

Teva Investigational Site 400, München

Teva Investigational Site 901, Donetsk

Teva Investigational Site 23, Coeur d'Alene

Teva Investigational Site 20, Tucson

Teva Investigational Site 16, Los Angeles

Teva Investigational Site 7, San Diego

Teva Investigational Site 17, Stanford

Teva Investigational Site 14, San Leandro

Teva Investigational Site 12, Seattle

Teva Investigational Site 5, Los Angeles

Teva Investigational Site 10, Boston

Teva Investigational Site 3, Chapel Hill

Teva Investigational Site 201, Brno

Teva Investigational Site 200, Olomouc

Teva Investigational Site 202, Prague

Teva Investigational Site 203, Prague

Teva Investigational Site 401, Dresden

Teva Investigational Site 751, Dresden

Teva Investigational Site 603, Dąbrówka

Teva Investigational Site 600, Elblag

Teva Investigational Site 602, Gmina Końskie

Teva Investigational Site 604, Lublin

Teva Investigational Site 601, Lublin

Teva Investigational Site 606, Warsaw

Teva Investigational Site 605, Wroclaw

Teva Investigational Site 701, Amadora

Teva Investigational Site 702, Coimbra

Teva Investigational Site 703, Porto

Teva Investigational Site 700, Porto

Teva Investigational Site 900, Kyiv

Teva Investigational Site 902, Kyiv

Teva Investigational Site 903, Kyiv

Teva Investigational Site 803, Bath

Teva Investigational Site 801, Leeds

Teva Investigational Site 800, London

Teva Investigational Site 802, Newcastle upon Tyne